...ests are available in 14 configurations including ...g Microgenics Antibody Technology, the SureStep&tr... immunoassay targeted to detect MDMA that has an a...ity to any isomer of methamphetamine or amphetamin...
...ests are available in 14 configurations including ...g Microgenics Antibody Technology, the SureStep&tr... immunoassay targeted to detect MDMA that has an a...ity to any isomer of methamphetamine or amphetamin...
AccuSign® DOA Series Opiates Test
...ests are available in 14 configurations including ...g Microgenics Antibody Technology, the SureStep&tr... immunoassay targeted to detect MDMA that has an a...ity to any isomer of methamphetamine or amphetamin...
Medicine Products:(Date:10/15/2008)... Cheers Soweto Hospice Pediatric Patients, WASHIN...ort from the,U.S. Agency for International Develop... Emergency Plan for AIDS Relief (PEPFAR) and other... Africa,s first children,s units,to provide specia...s with,life-threatening illnesses, including AIDS ...
(Date:10/15/2008)... and Staff in the Field Full-Time, SEIU,Helping To...ON, Oct. 15 /PRNewswire-USNewswire/ -- With just t...across the country are stepping up,their efforts t...ng about,the change working families need. Working...ies of events in battleground states each week to ...
(Date:10/15/2008)...Hand, LOUISVILLE, Ky., Oct. 15 /PRNewswire-USNews...h hand transplant recipient headed home,yesterday ...th stay in,Louisville. Armstrong received a new ri...rmed by Kleinert, Kutz & Associates and University...ewish Hospital., "I just want to thank the donor ...
(Date:10/15/2008)...college students from across the country to,discov...from infidelity and,promiscuity to pregnancy tests...- This survey, taken by 10,000 college,students ju... at what,students are up to when not hitting the b...., Among the Findings:, MYTH: Blondes have more ...
Breaking Medicine News(10 mins):Health News:Children with Life-Threatening Illnesses Receive Hospice Care 2Health News:SEIU Members Stepping up Their Efforts for Obama-Biden Ticket 2Health News:Fourth Hand Transplant Recipient Heads Home to California 2Health News:The Largest and Most Comprehensive College Dating and Sex Survey Uncovers Surprising Behaviors of Students In and Out of the Bedroom 2(Date:10/13/2008)...)-F Surface Treatment Maximizes,Endothelialization...ng-Term,Dual Antiplatelet Therapy, WASHINGTON, Oc...day,s,"Innovative Devices and Futuristic Therapies...diovascular Therapeutics (TCT) scientific,symposiu...tion, presented,12-month follow-up data from the A...
(Date:10/13/2008)...e Cancer Populations Facilitates ... 13 /- Rubicon Genomics, Inc. today,a...fy DNA samples for The,Cancer Atlas Genome Project...tandardize total genomic,DNA from 3,000 tissue and...enomePlex(TM) Whole Genome Amplification technolog...
(Date:10/12/2008)...ts designed for more uniform drug ...NGTON, Oct. 12 /- Boston,Sc... comprehensive data from,the TAXUS ATLAS clinical ...nter, single-arm, historically controlled trials, ...Eluting Stent System in a variety of,lesions and p...
(Date:10/10/2008)...wire/ -- Diplomat Specialty,Pharmacy announced tod...ecialty Pharmacy to be one of only three sites to ...imization Study for Multiple Sclerosis (TOP MS)., ...mine the benefits of a,specialty pharmacy therapy ...tient outcomes. Targeted patient outcomes will inc...
Breaking Medicine Technology:12-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions 212-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions 312-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions 4Rubicon Provides Genome Amplification for the Cancer Genome Atlas Project 2Rubicon Provides Genome Amplification for the Cancer Genome Atlas Project 3Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 2Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 3Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 4Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 5Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 6Diplomat Specialty Pharmacy Tapped by Teva Neuroscience for Therapy Optimization Study for Multiple Sclerosis (TOP MS) 2AARP Deeply Disappointed by Supreme Court Decision on Retiree Health Care Benefits 14970 1AARP Deeply Disappointed by Supreme Court Decision on Retiree Health Care Benefits 14970 2Cantel Medical Corp and National Safety Council Launch Joint Initiative to Prepare Businesses and Individuals for Flu Pandemic 14968 1Cantel Medical Corp and National Safety Council Launch Joint Initiative to Prepare Businesses and Individuals for Flu Pandemic 14968 2Cantel Medical Corp and National Safety Council Launch Joint Initiative to Prepare Businesses and Individuals for Flu Pandemic 14968 3WellPoints Health Plans to Cover Newly Approved Cancer Treatment 14966 1WellPoints Health Plans to Cover Newly Approved Cancer Treatment 14966 2Stress On The Campaign Trail One Issue All The Candidates Agree On 14964 1Stress On The Campaign Trail One Issue All The Candidates Agree On 14964 2...SINESS WIRE)--May 17, 2007 - Salix,Pharmaceuticals...of,18 investigator-initiated trials related to the... Disease Week(R) 2007, which will be,held May 19-2...largest and most prestigious meeting in the world ...re than 16,000 physicians,researchers and academi...
...SIS 301012 produced at least 45% additional,reduct...imally-tolerated lipid-lowering therapies, CARLSBA...Isis,Pharmaceuticals, Inc. announced updated resul... 301012 in patients with homozygous,familial hyper...ere,presented in March at the of Cardiology Annual...
Other Medicine Technology:Salix Pharmaceuticals Previews Digestive Disease Week 2007 2Salix Pharmaceuticals Previews Digestive Disease Week 2007 3Salix Pharmaceuticals Previews Digestive Disease Week 2007 4Salix Pharmaceuticals Previews Digestive Disease Week 2007 5Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 2Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 3Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 4Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 5